Our MR analysis indicates a potential renal protective effect of galectin-1 based on our observation that genetically elevated levels of galectin-1 are associated with higher eGFR in an independent study population of individuals with type 2 diabetes at high risk of diabetic nephropathy. The gene discussed is LGALS1; the disease is diabetic kidney disease.